14 results
8-K
EX-99.1
TSBX
Turnstone Biologics Corp.
14 Aug 24
Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
4:18pm
and pharmaceutical industry experience. The role of David Stojdl, Ph.D., Senior Vice President of Research and Discovery, was expanded to oversee all
DEF 14A
TSBX
Turnstone Biologics Corp.
22 Apr 24
Definitive proxy
4:28pm
(the “Exchange Act”), to oversee the Company’s corporate accounting and financial reporting processes and audits of its financial statements. The Audit Committee … performs several functions, including, among other things:
helping our Board of Directors oversee our corporate accounting and financial reporting
10-K
2023 FY
TSBX
Turnstone Biologics Corp.
21 Mar 24
Annual report
8:51pm
Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative clinical effectiveness research, along … , expand and protect our intellectual property portfolio;
expand our external manufacturing relationships;
oversee and maintain our manufacturing
10-Q
q0mjc4jii oklw6v5z
1 Sep 23
Quarterly report
4:39pm
424B4
o43t vh5rc1otda1
21 Jul 23
Prospectus supplement with pricing info
7:14pm
S-1/A
pg00e0ns
23 Jun 23
IPO registration (amended)
9:49pm
S-1
aemholpfoow
12 Jun 23
IPO registration
4:28pm
S-1
EX-10.8
33uh4qj3exk 4vgikz
12 Jun 23
IPO registration
4:28pm
DRS
3tosgb 9lv
15 May 23
Draft registration statement
12:00am
DRS
EX-10.8
76sgul
15 May 23
Draft registration statement
12:00am
- Prev
- 1
- Next